'Conferences & Events'
 EPM — Emerging Pharma Markets
VENUE : Holiday Inn, International Airport, Mumbai, India
DATE : 27 - 28 November 2012
E-Mail :
WEBSITE : http://www.emergingpharmamarkets.com/
DESCRIPTION : Learning the most successful strategies to swiftly enter high potential emerging pharma markets through in-depth guidance on:

• Regulatory landscape
• Sustaining price war
• Overcoming regional barriers
• Achieving systematic distribution

Capitalise on upcoming opportunities in the unexploited emerging pharma markets with in-depth focus on:

LATAM –unlocking the immense potential by gaining knowledge around the critical concerns including price war and ambiguous regulations

RUSSIA – combating the challenges around privatised market and learning effective ways to achieve profit oriented sustainable business

MIDDLE EAST – formulating strategies to overcome high entry barriers and capitalising on theses high value-low volume markets

NORTH AFRICA – addressing the complexities around the political instabilities, government dominance and product approvals by understanding the need of the region
ASIA PACIFIC – incorporating effective survival strategies in these highly competitive markets to achieve maximum gains and swift drug approvals

Build robust strategies to overcome challenges and avoid unnecessary entry delays by:

• Regulatory complexities
• Business environment
• Disease profile of the region
• Route to market
• Entry/exit strategies
• Pricing issues
• Market access
 
 Bio Pharma India Convention
VENUE : Grand Hyatt, Mumbai, India
DATE : 26 - 28 November 2012
E-Mail :
WEBSITE : http://www.terrapinn.com/conference/biopharma-india-convention/index.stm
DESCRIPTION : Biopharma India Convention 2012 is uniquely positioned a India's only eent where global and regional pharma companies, biotechs, CMOs, CROs, investors and many others come together to assess the latest trends, partnerships and solutions in India.Co-located with the Biologic Manufacturing World India and the Pharma Trials World India conferences, you can expect to network with more than 300 industrial stakeholders and players at one event to develop your business development strategies in India.

5 reasons why you need to attend

• Develop an Indian strategy for manufacturing and clinical operations by learning from more than 300+ key local and global pharmas and biotechs
• Establish key relationships with regulators, pharmas, biotechs, CROs, CMOs and investors for your business in India
• Learn manufacturing best practices and innovative technologies to fast-track drug development in India
• Overcome regulatory challenges to accelerate clinical development in India
• Gain insights to India’s lucrative biosimilars business
 
1
2
3
4
5
Latest Issue
Online Magazine